How To Get Wegovy: 5 Steps To A Prescription
A comprehensive guide to obtaining Wegovy prescription, eligibility, steps, costs, and alternatives for effective weight management.

Wegovy (semaglutide) is an FDA-approved prescription medication designed for chronic weight management in adults with obesity or overweight accompanied by weight-related medical conditions, used alongside a reduced-calorie diet and increased physical activity. Administered as a once-weekly subcutaneous injection, it mimics the GLP-1 hormone to reduce appetite and promote significant weight loss, with clinical trials demonstrating an average 15% body weight reduction.
What Is Wegovy?
Wegovy contains
semaglutide
, a glucagon-like peptide-1 (GLP-1) receptor agonist that regulates appetite and calorie intake by signaling the brain to feel full, thereby helping users eat less and achieve sustainable weight loss. Unlike diabetes treatments like Ozempic (which uses the same active ingredient at lower doses), Wegovy is specifically approved at 2.4 mg weekly for obesity management in non-diabetic patients.The medication comes in pre-filled, single-dose pens for easy self-administration in the abdomen, thigh, or upper arm. Dosing starts low (0.25 mg) and titrates up over 16 weeks to minimize side effects, reaching the maintenance dose of 2.4 mg. Clinical data from the STEP trials show it outperforms placebo, with participants losing about 35 pounds on average (15% of starting body weight) versus 6 pounds for placebo over 68 weeks.
Who Is Eligible for Wegovy?
Eligibility for Wegovy is determined by specific criteria set by the FDA. It is indicated for:
- Adults with
obesity
(BMI ≥30 kg/m²). - Adults who are
overweight
(BMI ≥27 kg/m²) with at least one weight-related comorbidity, such as hypertension, dyslipidemia, type 2 diabetes, or cardiovascular disease.
Patients must commit to lifestyle changes, including diet and exercise. It is not approved for cosmetic weight loss or in children under 12 (though a lower dose is approved for adolescents 12+ with obesity). Contraindications include personal/family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.
| BMI Category | Eligibility Criteria | Example Comorbidities |
|---|---|---|
| Obesity (≥30 kg/m²) | Yes, with diet/exercise | N/A |
| Overweight (≥27 kg/m²) | Yes, plus ≥1 comorbidity | High BP, high cholesterol |
| Normal/Underweight | No | N/A |
BMI calculators are available online or via healthcare providers to confirm eligibility.
How to Get a Wegovy Prescription
Obtaining Wegovy requires a prescription from a licensed healthcare provider. Follow these steps:
- Consult a Doctor: Schedule an appointment with a primary care physician, endocrinologist, or obesity specialist. Telehealth platforms like Noom, Ro, or Calibrate offer virtual consultations tailored for weight loss medications.
- Medical Evaluation: Discuss medical history, BMI, comorbidities, and lifestyle. Expect lab tests (e.g., thyroid function, A1C) to rule out contraindications.
- Prescription Issued: If eligible, your provider will prescribe Wegovy, specifying the starter kit for titration.
- Fill the Prescription: Use pharmacies like CVS, Walgreens, or online services. Check insurance coverage first.
- Start Treatment: Receive training on injection technique; follow the dosing schedule.
Telemedicine has made access easier, with providers shipping pens directly after approval. Always verify state-specific telehealth regulations.
Cost of Wegovy and Insurance Coverage
Wegovy costs approximately $1,300–$1,700 per month without insurance, but coverage varies. Medicare Part D may cover it for obesity since 2024 expansions, while private insurers often require prior authorization, proof of BMI/comorbidities, and failure of lifestyle interventions. Novo Nordisk’s savings card reduces out-of-pocket costs to $0–$225/month for eligible commercially insured patients (up to 13 fills).
Uninsured patients can use manufacturer coupons or patient assistance programs. Compounded semaglutide (non-FDA-approved) is cheaper but riskier due to lack of regulation.
| Scenario | Monthly Cost Estimate |
|---|---|
| With Insurance + Savings Card | $0–$225 |
| Without Insurance | $1,300–$1,700 |
| Medicare Part D | Varies; often covered |
Shortages and Availability
Wegovy has faced intermittent shortages since 2023 due to high demand, but Novo Nordisk reports improved supply as of 2025, prioritizing lower doses. Use the FDA shortage list or NovoCare to check local availability. Alternatives like Zepbound (tirzepatide) may be suggested during shortages.
How to Use Wegovy
Inject subcutaneously once weekly, any time of day, with or without food. Rotate sites. Titration schedule:
- Weeks 1–4: 0.25 mg
- Weeks 5–8: 0.5 mg
- Weeks 9–12: 1 mg
- Weeks 13–16: 1.7 mg
- Week 17+: 2.4 mg
Miss a dose if >5 days late; resume next week. Store pens in fridge (unused) or at room temp ≤28 days.
Side Effects and Safety
Common side effects are gastrointestinal: nausea (44%), diarrhea (30%), vomiting (24%), constipation (24%). Most mild, improve with time. Serious risks include pancreatitis, gallbladder issues, kidney problems, and thyroid tumors (boxed warning). Monitor for hypoglycemia if on insulin. Discontinue if severe symptoms occur.
In STEP trials, 17% discontinued due to adverse events vs. 22% on placebo. Cardiovascular benefits noted in related studies.
Wegovy Results: What to Expect
From a 68-week STEP 1 trial (1,961 adults): Wegovy users lost 15% body weight (35 lbs from 232 lbs avg.) vs. 2.5% on placebo. 83% achieved ≥5% loss. A 64-week pill study showed 14% loss (33 lbs). Maintenance requires continued use; weight regain occurs upon stopping.
Alternatives to Wegovy
- Zepbound (tirzepatide): Dual GLP-1/GIP agonist; up to 20% loss.
- Saxenda (liraglutide): Daily GLP-1 injection.
- Phentermine: Short-term appetite suppressant.
- Orlistat (Xenical): Fat absorption blocker.
- Bariatric surgery: For severe obesity.
Frequently Asked Questions (FAQs)
Is Wegovy right for me?
If you have obesity (BMI ≥30) or overweight (BMI ≥27) with comorbidities, and commit to diet/exercise, yes. Consult a doctor.
How much weight can I lose on Wegovy?
Average 15% (35 lbs) in 68 weeks with lifestyle changes; 83% lose ≥5%.
Does insurance cover Wegovy?
Often yes with prior authorization; savings programs available.
What are Wegovy’s side effects?
Mostly GI issues like nausea; serious risks rare.
Can I get Wegovy online?
Yes, via telehealth providers after consultation.
How long to take Wegovy?
Long-term for chronic management; discuss with provider.
References
- FAQs – Wegovy — Novo Nordisk. 2025. https://www.wegovy.com/obesity/starting-wegovy/faq.html
- Wegovy (semaglutide): a new weight loss drug for chronic weight management — PMC (PubMed Central). 2021-12-16. https://pmc.ncbi.nlm.nih.gov/articles/PMC8717485/
Read full bio of Sneha Tete














